A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.

by Kyle Bagenstose

Preliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.

by Sandra Gordon

Potential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.

by Taneia Surles

‘Practice-changing’ research shows adding immunotherapy before and after surgery reduced recurrences for early-stage gastric cancer.

by Laura Gesualdi Gilmore

Forward Look

Breast surgeon Maria Margarete Karsten discusses how using patient-reported outcomes can improve quality of life.

by Ashley P. Taylor

Forward Look

Researchers explore adding immunotherapy before surgery to help improve outcomes for people with locally advanced disease.

by Risa Kerslake

Forward Look

When exposed to a near-infrared laser, injected microparticles release heat and chemotherapy directly to the tumor.

by Leah Lawrence

Researchers explore the potential of immune checkpoint inhibitors before surgery to prevent recurrence in several cancers.

by Kendall K. Morgan

PSMA-targeted therapy, which delivers radiation directly to cancer cells, provides a new approach for those whose prostate cancer stops responding to other treatments.

by Stephen Ornes

Healthy Habits

Adding calcium-rich foods to your diet may reduce colorectal cancer risk.

by Anne Danahy